Jefferies Group LLC Idera Pharmaceuticals, Inc. Call Options Transaction History

Jefferies Group LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 16, 2021	SELL	$1.01 - $1.58 $50,500 - $79,000	-50,000 Closed	0 $0
Q1 2021 Sep 21, 2023	BUY	$1.23 - $5.98 $61,500 - $299,000	50,000 New	50,000 $65,000
Q1 2021 May 14, 2021	BUY	$1.23 - $5.98 $61,500 - $299,000	50,000 New	50,000 $65,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.